PPT-Global Initiative for Asthma (GINA)

Whats new in GINA 2015 Addon tiotropium by softmist inhaler is a new other controller option for Steps 4 and 5 in patients 18 years with history of exacerbations T iotropium was previously described in GINA as an addon option on the basis of clinical trial evidence . Quality asthma care involves not only initial diagnosis and treatment to achieve asthma control but also longterm regular followup care to maintain control Asthma control focuses on two domains 1 reducing impairment the frequency and intensity of sy It is a chronic inflammatory disorder of the airways in which many cells and cellular elements play a role, in particular, mast cells,eosinophils,T lymphocytes, macrophages, neutrophils and epithelial cells.. 1. Centers for Disease Control and Prevention (CDC). https://www.cdc.gov/asthma/most_recent_data.htm. Accessed August 14, 2018.. 26.5 million people. in the US have asthma. 1. 3.3 million children and 9.1 million adults have inadequately controlled asthma. This slide set is restricted for academic and educational purposes only. No additions or changes may be made to slides. Use of the slide set or of individual slides for commercial or promotional purposes requires approval from GINA. What’s new in GINA 2019?. This slide set is restricted for academic and educational purposes only. No additions or changes . may be made to slides. . Use of the slide set or of individual slides for commercial or promotional purposes requires approval from GINA. . for early detection and treatment. Ondřej. . Rybníček. A. l. lerg. y. . unit. , P. a. e. diatric. . Dept. .. , FN BRNO. Sensitization. . . allergic. rhinitis. atopic. . eczema. bronchial. in the Treatment of . Asthma and COPD. Margaret Miklich, . PharmD. , BCACP. Clinical Assistant Professor. 1. m. argaret.miklich@temple.edu. I have no conflicts of interest to disclose.. 2. Pharmacist Objectives. in the Treatment of . Asthma and COPD. Margaret Miklich, . PharmD. , BCACP. Clinical Assistant Professor. 1. m. argaret.miklich@temple.edu. I have no conflicts of interest to disclose.. 2. Pharmacist Objectives. applies, more information on the exceptions to GINA, Status: GINA does not prevent health insurers from making decisions about eligibility, coverage or premiums based on a person applies, more information on the exceptions to GINA, diagnosis of a disease or health condition. This is true even if the condition is a genetic DISEASE�OR�WAS�DIAGNOSED�I ember 2012, the initiative gathers a broad spectrum of world leaders and use the transformative power of education to build a better future for all. The Initiative's three main priorities are to: Impr Updates inLaura Vaughan MDClinical Assistant Professor of MedicineStanford UniversityGINA slides used in this presentation are reproduced with permissionNo financial disclosuresSerious Consequences98 The airway (bronchial tubes) can become swollen and the muscle around the airway tightens. . The result is a narrowed airway. Symptoms. Wheezing. Coughing. Shortness of breath. Chest tightness. Increased rate of breathing. GINA structure. Board of Directors. Chair. : Søren Pedersen, . MD. Dissemination & Implementation Committee. Chair: L-P Boulet, MD . Science Committee. Chair: Helen Reddel, MBBS PhD. GINA ASSEMBLY.